Granulocyte colony-stimulating factor and the risk of secondary myeloid malignancy after etoposide treatment
Mary V. Relling(St. Jude Children's Research Hospital), Ching‐Hon Pui(St. Jude Children's Research Hospital), William E. Evans(St. Jude Children's Research Hospital), Larry E. Kun(St. Jude Children's Research Hospital), Javier G. Blanco(Biomedical Research Institute), Frederick G. Behm(St. Jude Children's Research Hospital), John T. Sandlund(St. Jude Children's Research Hospital), James M. Boyett(University of Illinois Chicago), Gaston K. Rivera(St. Jude Children's Research Hospital), Susana C. Raimondi(St. Jude Children's Research Hospital)
Cited by 152
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Treatment of Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2006|2k